Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.
KTAL Shreveport on MSN17h
Shreveport physicists publish four papers on stereotactic radiotherapyPhysicists at a hospital in Shreveport have published four publications after a year of groundbreaking research in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback